[KLK] YoY Annual (Unaudited) Result on 30-Sep-2023 [#4]

Announcement Date
22-Nov-2023
Admission Sponsor
-
Sponsor
-
Financial Year
30-Sep-2023
Quarter
30-Sep-2023 [#4]
Profit Trend
YoY- -61.49%
View:
Show?
Annual (Unaudited) Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 22,273,698 23,647,586 27,149,474 19,915,796 15,595,956 15,533,887 18,400,500 3.23%
PBT 1,183,482 1,152,227 3,219,478 2,976,425 1,185,730 823,928 1,117,380 0.96%
Tax -445,357 -161,530 -781,121 -524,373 -328,681 -173,195 -313,276 6.03%
NP 738,125 990,697 2,438,357 2,452,052 857,049 650,733 804,104 -1.41%
-
NP to SH 590,961 834,259 2,166,290 2,257,584 772,604 617,505 753,328 -3.96%
-
Tax Rate 37.63% 14.02% 24.26% 17.62% 27.72% 21.02% 28.04% -
Total Cost 21,535,573 22,656,889 24,711,117 17,463,744 14,738,907 14,883,154 17,596,396 3.42%
-
Net Worth 13,604,074 14,321,629 14,285,568 11,858,689 10,827,926 10,362,115 11,427,081 2.94%
Dividend
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Div 217,665 215,687 215,631 215,612 161,771 159,744 159,744 5.28%
Div Payout % 36.83% 25.85% 9.95% 9.55% 20.94% 25.87% 21.21% -
Equity
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Net Worth 13,604,074 14,321,629 14,285,568 11,858,689 10,827,926 10,362,115 11,427,081 2.94%
NOSH 1,088,325 1,081,017 1,081,017 1,081,017 1,081,017 1,064,965 1,064,965 0.36%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 3.31% 4.19% 8.98% 12.31% 5.50% 4.19% 4.37% -
ROE 4.34% 5.83% 15.16% 19.04% 7.14% 5.96% 6.59% -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
RPS 2,046.60 2,192.77 2,518.14 1,847.37 1,446.11 1,458.63 1,727.80 2.85%
EPS 54.30 77.40 200.90 209.30 72.00 58.00 70.70 -4.29%
DPS 20.00 20.00 20.00 20.00 15.00 15.00 15.00 4.90%
NAPS 12.50 13.28 13.25 11.00 10.04 9.73 10.73 2.57%
Adjusted Per Share Value based on latest NOSH - 1,081,017
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
RPS 1,975.20 2,097.04 2,407.58 1,766.11 1,383.03 1,377.52 1,631.73 3.23%
EPS 52.41 73.98 192.10 200.20 68.51 54.76 66.80 -3.95%
DPS 19.30 19.13 19.12 19.12 14.35 14.17 14.17 5.27%
NAPS 12.0639 12.7002 12.6683 10.5161 9.6021 9.189 10.1334 2.94%
Price Multiplier on Financial Quarter End Date
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Date 30/09/24 29/09/23 30/09/22 30/09/21 30/09/20 30/09/19 28/09/18 -
Price 20.54 21.40 20.70 20.12 22.80 23.08 24.96 -
P/RPS 1.00 0.98 0.82 1.09 1.58 1.58 1.44 -5.89%
P/EPS 37.83 27.66 10.30 9.61 31.83 39.80 35.29 1.16%
EY 2.64 3.61 9.71 10.41 3.14 2.51 2.83 -1.15%
DY 0.97 0.93 0.97 0.99 0.66 0.65 0.60 8.32%
P/NAPS 1.64 1.61 1.56 1.83 2.27 2.37 2.33 -5.67%
Price Multiplier on Announcement Date
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Date 26/11/24 22/11/23 23/11/22 23/11/21 18/11/20 19/11/19 14/11/18 -
Price 21.62 21.52 21.20 20.26 23.32 22.50 24.92 -
P/RPS 1.06 0.98 0.84 1.10 1.61 1.54 1.44 -4.97%
P/EPS 39.82 27.82 10.55 9.67 32.55 38.80 35.23 2.06%
EY 2.51 3.59 9.48 10.34 3.07 2.58 2.84 -2.03%
DY 0.93 0.93 0.94 0.99 0.64 0.67 0.60 7.57%
P/NAPS 1.73 1.62 1.60 1.84 2.32 2.31 2.32 -4.76%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment